{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:43:01Z","timestamp":1783132981851,"version":"3.54.6"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["no. 81670557"],"award-info":[{"award-number":["no. 81670557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2016YFC1000700"],"award-info":[{"award-number":["2016YFC1000700"]}]},{"name":"National Key Research and Development Program of China","award":["2016YFC1000703"],"award-info":[{"award-number":["2016YFC1000703"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10585-022-10165-8","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:05:19Z","timestamp":1650560719000},"page":"603-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6"],"prefix":"10.1007","volume":"39","author":[{"given":"Yunyun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5881-0477","authenticated-orcid":false,"given":"Guihu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"10165_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040952","author":"MA Lisio","year":"2019","unstructured":"Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C (2019) High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20040952","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10165_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc.2016.113","volume":"17","author":"AN Karnezis","year":"2017","unstructured":"Karnezis AN, Cho KR, Gilks CB, Pearce CL, Huntsman DG (2017) The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat Rev Cancer 17(1):65\u201374. https:\/\/doi.org\/10.1038\/nrc.2016.113","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10165_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10147-016-0985-x","volume":"21","author":"S Komiyama","year":"2016","unstructured":"Komiyama S, Katabuchi H, Mikami M, Nagase S, Okamoto A, Ito K, Morishige K, Suzuki N, Kaneuchi M, Yaegashi N, Udagawa Y, Yoshikawa H (2016) Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer. Int J Clin Oncol 21(3):435\u201346. https:\/\/doi.org\/10.1007\/s10147-016-0985-x","journal-title":"Int J Clin Oncol"},{"key":"10165_CR4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.28932","author":"KM Elias","year":"2017","unstructured":"Elias KM, Fendler W, Stawiski K, Fiascone SJ, Vitonis AF, Berkowitz RS, Frendl G, Konstantinopoulos P, Crum CP, Kedzierska M, Cramer DW, Chowdhury D (2017) Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife. https:\/\/doi.org\/10.7554\/eLife.28932","journal-title":"Elife"},{"key":"10165_CR5","doi-asserted-by":"publisher","DOI":"10.1063\/1.5024386","author":"C Novak","year":"2018","unstructured":"Novak C, Horst E, Mehta G (2018) Review: mechanotransduction in ovarian cancer: shearing into the unknown. APL Bioeng. https:\/\/doi.org\/10.1063\/1.5024386","journal-title":"APL Bioeng"},{"issue":"8","key":"10165_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/15384047.2018.1451286","volume":"19","author":"I Giusti","year":"2018","unstructured":"Giusti I, Di Francesco M, D\u2019Ascenzo S, Palmerini MG, Macchiarelli G, Carta G, Dolo V (2018) Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior. Cancer Biol Ther 19(8):722\u2013734. https:\/\/doi.org\/10.1080\/15384047.2018.1451286","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"10165_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-019-1049-4","volume":"18","author":"W Feng","year":"2019","unstructured":"Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z (2019) Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer 18(1):124. https:\/\/doi.org\/10.1186\/s12943-019-1049-4","journal-title":"Mol Cancer"},{"issue":"6","key":"10165_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30(6):836\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.009","journal-title":"Cancer Cell"},{"issue":"1","key":"10165_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2015.07.014","volume":"367","author":"MK Tang","year":"2015","unstructured":"Tang MK, Wong AS (2015) Exosomes: emerging biomarkers and targets for ovarian cancer. Cancer Lett 367(1):26\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.014","journal-title":"Cancer Lett"},{"key":"10165_CR10","doi-asserted-by":"publisher","unstructured":"Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ (2018) Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol 15(10):617\u201338. https:\/\/\u200bdoi.\u200borg\/https:\/\/doi.org\/10.1038\/s41571-018-0036-9","DOI":"10.1038\/s41571-018-0036-9"},{"key":"10165_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104381","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Shoorei H, Taheri M (2020) miRNA profile in ovarian cancer. Exp Mol Pathol. https:\/\/doi.org\/10.1016\/j.yexmp.2020.104381","journal-title":"Exp Mol Pathol"},{"issue":"5","key":"10165_CR12","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1002\/jcp.26095","volume":"233","author":"B Deb","year":"2018","unstructured":"Deb B, Uddin A, Chakraborty S (2018) miRNAs and ovarian cancer: an overview. J Cell Physiol 233(5):3846\u20133854. https:\/\/doi.org\/10.1002\/jcp.26095","journal-title":"J Cell Physiol"},{"key":"10165_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ebiom.2019.08.057","volume":"47","author":"N Wang","year":"2019","unstructured":"Wang N, Song L, Xu Y, Zhang L, Wu Y, Guo J, Ji W, Li L, Zhao J, Zhang X, Zhan L (2019) Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2\/ROS and Nrf2\/PD-L1 signaling. EBioMedicine 47:65\u201377. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.057","journal-title":"EBioMedicine"},{"key":"10165_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117296","author":"H Chao","year":"2020","unstructured":"Chao H, Zhang M, Hou H, Zhang Z, Li N (2020) HOTAIRM1 suppresses cell proliferation and invasion in ovarian cancer through facilitating ARHGAP24 expression by sponging miR-106a-5p. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.117296","journal-title":"Life Sci"},{"issue":"5","key":"10165_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","volume":"20","author":"W Yan","year":"2018","unstructured":"Yan W, Wu X, Zhou W, Fong MY, Cao M, Liu J, Liu X, Chen CH, Fadare O, Pizzo DP, Wu J, Liu L, Liu X, Chin AR, Ren X, Chen Y, Locasale JW, Wang SE (2018) Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 20(5):597\u2013609. https:\/\/doi.org\/10.1038\/s41556-018-0083-6","journal-title":"Nat Cell Biol"},{"issue":"20","key":"10165_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.18632\/aging.203645","volume":"13","author":"Y Lai","year":"2021","unstructured":"Lai Y, Dong L, Jin H, Li H, Sun M, Li J (2021) Exosome long non-coding RNA SOX2-OT contributes to ovarian cancer malignant progression by miR-181b-5p\/SCD1 signaling. Aging (Albany, NY) 13(20):236\u2013238. https:\/\/doi.org\/10.18632\/aging.203645","journal-title":"Aging (Albany, NY)"},{"issue":"3","key":"10165_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41419-018-0392-5","volume":"9","author":"M Hu","year":"2018","unstructured":"Hu M, Guo G, Huang Q, Cheng C, Xu R, Li A, Liu N, Liu S (2018) The harsh microenvironment in infarcted heart accelerates transplanted bone marrow mesenchymal stem cells injury: the role of injured cardiomyocytes-derived exosomes. Cell Death Dis 9(3):357. https:\/\/doi.org\/10.1038\/s41419-018-0392-5","journal-title":"Cell Death Dis"},{"key":"10165_CR18","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92\u2013D97. https:\/\/doi.org\/10.1093\/nar\/gkt1248","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10165_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","volume":"18","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Liu W, Zhang HM, Xie GY, Miao YR, Xia M, Guo AY (2020) hTFtarget: a comprehensive database for regulations of human transcription factors and their targets. Genom Proteom Bioinf 18(2):120\u2013128. https:\/\/doi.org\/10.1016\/j.gpb.2019.09.006","journal-title":"Genom Proteom Bioinf"},{"issue":"D1","key":"10165_CR20","doi-asserted-by":"publisher","first-page":"D87","DOI":"10.1093\/nar\/gkz1001","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M, Baranasic D, Santana-Garcia W, Tan G, Cheneby J, Ballester B, Parcy F, Sandelin A, Lenhard B, Wasserman WW, Mathelier A (2020) JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 48(D1):D87\u2013D92. https:\/\/doi.org\/10.1093\/nar\/gkz1001","journal-title":"Nucleic Acids Res"},{"issue":"7\u20138","key":"10165_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41417-020-0195-6","volume":"28","author":"Z Ruan","year":"2021","unstructured":"Ruan Z, Lu L, Zhang L, Dong M (2021) Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt\/beta-catenin signaling pathway. Cancer Gene Ther 28(7\u20138):785\u2013798. https:\/\/doi.org\/10.1038\/s41417-020-0195-6","journal-title":"Cancer Gene Ther"},{"issue":"14","key":"10165_CR22","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.7150\/thno.43865","volume":"10","author":"J Li","year":"2020","unstructured":"Li J, Xu J, Li L, Ianni A, Kumari P, Liu S, Sun P, Braun T, Tan X, Xiang R, Yue S (2020) MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway. Theranostics 10(14):6467\u20136482. https:\/\/doi.org\/10.7150\/thno.43865","journal-title":"Theranostics"},{"issue":"1","key":"10165_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13046-019-1067-5","volume":"38","author":"C Dou","year":"2019","unstructured":"Dou C, Xu Q, Liu J, Wang Y, Zhou Z, Yao W, Jiang K, Cheng J, Zhang C, Tu K (2019) SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production. J Exp Clin Cancer Res 38(1):70. https:\/\/doi.org\/10.1186\/s13046-019-1067-5","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10165_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-020-01637-4","volume":"39","author":"Q Zhong","year":"2020","unstructured":"Zhong Q, Fang Y, Lai Q, Wang S, He C, Li A, Liu S, Yan Q (2020) CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R\/STAT3 signaling. J Exp Clin Cancer Res 39(1):132. https:\/\/doi.org\/10.1186\/s13046-020-01637-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10165_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"6","key":"10165_CR26","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.3892\/ol.2019.10220","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Xu S, Liu X (2019) MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing. Oncol Lett 17(6):5601\u20135607. https:\/\/doi.org\/10.3892\/ol.2019.10220","journal-title":"Oncol Lett"},{"issue":"2","key":"10165_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/cbf.3583","volume":"39","author":"X Zhang","year":"2021","unstructured":"Zhang X, Sheng Y, Li B, Wang Q, Liu X, Han J (2021) Ovarian cancer derived PKR1 positive exosomes promote angiogenesis by promoting migration and tube formation in vitro. Cell Biochem Funct 39(2):308\u201316. https:\/\/doi.org\/10.1002\/cbf.3583","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10165_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-020-1137-5","volume":"19","author":"C Lu","year":"2020","unstructured":"Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, Chen L, Lyu X, Shi Z, Yan W, You Y (2020) DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer 19(1):28. https:\/\/doi.org\/10.1186\/s12943-020-1137-5","journal-title":"Mol Cancer"},{"issue":"6","key":"10165_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/msj.20150","volume":"76","author":"A DiFeo","year":"2009","unstructured":"DiFeo A, Narla G, Martignetti JA (2009) Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment. Mt Sinai J Med 76(6):557\u2013566. https:\/\/doi.org\/10.1002\/msj.20150","journal-title":"Mt Sinai J Med"},{"issue":"12","key":"10165_CR30","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1158\/1078-0432.CCR-06-0054","volume":"12","author":"A DiFeo","year":"2006","unstructured":"DiFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose SL, Kalir T, Yao S, Levine A, Birrer MJ, Bonome T, Friedman SL, Buller RE, Martignetti JA (2006) Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res 12(12):3730\u20133739. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0054","journal-title":"Clin Cancer Res"},{"issue":"44","key":"10165_CR31","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1038\/sj.onc.1209611","volume":"25","author":"A DiFeo","year":"2006","unstructured":"DiFeo A, Narla G, Camacho-Vanegas O, Nishio H, Rose SL, Buller RE, Friedman SL, Walsh MJ, Martignetti JA (2006) E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. Oncogene 25(44):6026\u20136031. https:\/\/doi.org\/10.1038\/sj.onc.1209611","journal-title":"Oncogene"},{"issue":"6","key":"10165_CR32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s12015-019-09911-5","volume":"15","author":"S Parte","year":"2019","unstructured":"Parte S, Virant-Klun I, Patankar M, Batra SK, Straughn A, Kakar SS (2019) PTTG1: a unique regulator of stem\/cancer stem cells in the ovary and ovarian cancer. Stem Cell Rev Rep 15(6):866\u2013879. https:\/\/doi.org\/10.1007\/s12015-019-09911-5","journal-title":"Stem Cell Rev Rep"},{"issue":"6","key":"10165_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cts.12413","volume":"9","author":"I Nakachi","year":"2016","unstructured":"Nakachi I, Helfrich BA, Spillman MA, Mickler EA, Olson CJ, Rice JL, Coldren CD, Heasley LE, Geraci MW, Stearman RS (2016) PTTG1 levels are predictive of saracatinib sensitivity in ovarian cancer cell lines. Clin Transl Sci 9(6):293\u2013301. https:\/\/doi.org\/10.1111\/cts.12413","journal-title":"Clin Transl Sci"},{"key":"10165_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16091510","author":"SN Chen","year":"2019","unstructured":"Chen SN, Chang R, Lin LT, Chern CU, Tsai HW, Wen ZH, Li YH, Li CJ, Tsui KH (2019) MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph16091510","journal-title":"Int J Environ Res Public Health"},{"key":"10165_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ncomms14470","volume":"8","author":"A Yokoi","year":"2017","unstructured":"Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F, Ochiya T (2017) Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer. Nat Commun 8:144\u2013170. https:\/\/doi.org\/10.1038\/ncomms14470","journal-title":"Nat Commun"},{"key":"10165_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105041","author":"J Chen","year":"2020","unstructured":"Chen J, Fei X, Wang J, Cai Z (2020) Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2020.105041","journal-title":"Pharmacol Res"},{"key":"10165_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153395","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhao J, Tan L, Lin S, Long M, Peng X (2021) LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p\/PPP2R2A axis. Pathol Res Pract. https:\/\/doi.org\/10.1016\/j.prp.2021.153395","journal-title":"Pathol Res Pract"},{"issue":"14","key":"10165_CR38","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/1759-7714.14043","volume":"12","author":"T Liu","year":"2021","unstructured":"Liu T, Yang C, Wang W, Liu C (2021) LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p\/MYLI9 axis. Thorac Cancer 12(14):2104\u20132112. https:\/\/doi.org\/10.1111\/1759-7714.14043","journal-title":"Thorac Cancer"},{"issue":"1","key":"10165_CR39","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1080\/21655979.2021.1960774","volume":"12","author":"P Du","year":"2021","unstructured":"Du P, Luo K, Li G, Zhu J, Xiao Q, Li Y, Zhang X (2021) Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3\/HIF-1alpha pathway. Bioengineered 12(1):5028\u20135044. https:\/\/doi.org\/10.1080\/21655979.2021.1960774","journal-title":"Bioengineered"},{"issue":"1","key":"10165_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.26355\/eurrev_202001_19894","volume":"24","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Len TY, Zhang SX, Zhao QH, Yang LH (2020) Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN\/AKT signaling pathway. Eur Rev Med Pharmacol Sci 24(1):43\u201354. https:\/\/doi.org\/10.26355\/eurrev_202001_19894","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"19","key":"10165_CR41","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.1111\/jcmm.16801","volume":"25","author":"J Li","year":"2021","unstructured":"Li J, Hu C, Chao H, Zhang Y, Li Y, Hou J, Huang L (2021) Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma. J Cell Mol Med 25(19):9183\u201398. https:\/\/doi.org\/10.1111\/jcmm.16801","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10165_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13048-021-00826-9","volume":"14","author":"J Xiong","year":"2021","unstructured":"Xiong J, He X, Xu Y, Zhang W, Fu F (2021) MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer. J Ovarian Res 14(1):74. https:\/\/doi.org\/10.1186\/s13048-021-00826-9","journal-title":"J Ovarian Res"},{"issue":"14","key":"10165_CR43","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.26355\/eurrev_202007_22221","volume":"24","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Qin XP, Lang YP, Kou D, Shao ZW (2020) Circular RNA circ-SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6. Eur Rev Med Pharmacol Sci 24(14):7563. https:\/\/doi.org\/10.26355\/eurrev_202007_22221","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"14","key":"10165_CR44","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.26355\/eurrev_202007_22228","volume":"24","author":"HP Liu","year":"2020","unstructured":"Liu HP, Lv D, Wang JY, Zhang Y, Chang JF, Liu ZT, Tang N (2020) Long noncoding RNA PCAT-1 promoted ovarian cancer cell proliferation and invasion by suppressing KLF6. Eur Rev Med Pharmacol Sci 24(14):7566. https:\/\/doi.org\/10.26355\/eurrev_202007_22228","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"15","key":"10165_CR45","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.26355\/eurrev_202008_22452","volume":"24","author":"Y Li","year":"2020","unstructured":"Li Y, Hou CZ, Dong YL, Zhu L, Xu H (2020) Long noncoding RNA LINP1 promoted proliferation and invasion of ovarian cancer via inhibiting KLF6. Eur Rev Med Pharmacol Sci 24(15):7918. https:\/\/doi.org\/10.26355\/eurrev_202008_22452","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10165_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.652322","author":"Y Cui","year":"2021","unstructured":"Cui Y, Wang D, Xie M (2021) Tumor-derived extracellular vesicles promote activation of carcinoma-associated fibroblasts and facilitate invasion and metastasis of ovarian cancer by carrying miR-630. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.652322","journal-title":"Front Cell Dev Biol"},{"key":"10165_CR47","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1017\/S1462399410001699","volume":"12","author":"VE Smith","year":"2010","unstructured":"Smith VE, Franklyn JA, McCabe CJ (2010) Pituitary tumor-transforming gene and its binding factor in endocrine cancer. Expert Rev Mol Med 12:e38. https:\/\/doi.org\/10.1017\/S1462399410001699","journal-title":"Expert Rev Mol Med"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-022-10165-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-022-10165-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-022-10165-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T11:06:08Z","timestamp":1659179168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-022-10165-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10165"],"URL":"https:\/\/doi.org\/10.1007\/s10585-022-10165-8","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study got the approval of the Ethics Committee of Xi'an Jiaotong University Second Affiliated Hospital (S2016-120-02), following the Declaration of Helsinki. The informed consent was conferred by each eligible participant. This study was approved by the Ethical Committee of Xi'an Jiaotong University Second Affiliated Hospital (2016127) and the animals were treated on the basis of the standards of animal ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}